Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-14 Purchase | 2024-05-15 09:16 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 1,940 | $6.74 | $13,076 | 3,246,424 (Direct) | View |
| 2024-05-10 Purchase | 2024-05-13 08:51 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 2,000 | $6.4 | $12,800 | 3,244,484 (Direct) | View |
| 2024-05-10 Purchase | 2024-05-13 08:49 am | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off | 500 | $6.29 | $3,145 | 1,504,319 (Direct) | View |
| 2024-05-10 Purchase | 2024-05-13 08:47 am | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 1,113 | $6.32 | $7,034 | 1,493,068 (Direct) | View |
| 2024-03-18 Purchase | 2024-03-19 08:00 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 5,000 | $10.29 | $51,450 | 3,242,484 (Direct) | View |
| 2023-10-10 Purchase | 2023-10-12 4:05 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 640 | $11.08 | $7,091 | 3,237,484 (Direct) | View |
| 2023-10-06 Purchase | 2023-10-10 08:30 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 1,080 | $11.21 | $12,105 | 3,236,844 (Direct) | View |
| 2023-10-04 Purchase | 2023-10-06 08:37 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 3,220 | $11.01 | $35,455 | 3,235,764 (Direct) | View |
| 2023-08-15 Purchase | 2023-08-16 4:05 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 350 | $14.61 | $5,112 | 3,232,544 (Direct) | View |
| 2023-08-08 Purchase | 2023-08-11 6:07 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 300 | $14.73 | $4,418 | 3,232,194 (Direct) | View |
| 2023-07-31 Purchase | 2023-08-01 08:00 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 860 | $13.88 | $11,937 | 2,595,000 (Direct) | View |
| 2023-07-28 Purchase | 2023-07-31 08:00 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 2,584 | $13.91 | $35,943 | 2,594,140 (Direct) | View |
| 2023-07-27 Purchase | 2023-07-28 08:00 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 1,556 | $13.98 | $21,753 | 2,591,556 (Direct) | View |
| 2023-07-26 Purchase | 2023-07-27 06:52 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 10,000 | $13.97 | $139,700 | 2,590,000 (Direct) | View |
| 2023-07-20 Purchase | 2023-07-24 4:45 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 335 | $14.92 | $4,998 | 3,231,894 (Direct) | View |
| 2023-07-20 Purchase | 2023-07-24 4:45 pm | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 8,238 | $14.47 | $119,224 | 2,580,000 (Direct) | View |
| 2023-07-19 Purchase | 2023-07-20 06:30 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 8,000 | $14.84 | $118,720 | 2,571,762 (Direct) | View |
| 2023-07-19 Purchase | 2023-07-20 06:30 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 200 | $14.33 | $2,866 | 3,231,559 (Direct) | View |
| 2023-07-18 Purchase | 2023-07-19 08:06 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 9,149 | $14.84 | $135,771 | 2,563,762 (Direct) | View |
| 2023-07-07 Purchase | 2023-07-18 08:34 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 260 | $15.52 | $4,035 | 3,231,359 (Direct) | View |
| 2023-07-12 Purchase | 2023-07-13 08:30 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 3,285 | $15.09 | $49,571 | 2,554,613 (Direct) | View |
| 2023-07-11 Purchase | 2023-07-12 08:30 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 10,000 | $15.36 | $153,600 | 2,551,328 (Direct) | View |
| 2023-07-07 Purchase | 2023-07-10 08:00 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 8,948 | $15.19 | $135,920 | 2,541,328 (Direct) | View |
| 2023-07-06 Purchase | 2023-07-07 08:04 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 3,179 | $15.01 | $47,717 | 2,532,380 (Direct) | View |
| 2023-07-06 Purchase | 2023-07-07 08:03 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 320 | $14.88 | $4,762 | 3,231,099 (Direct) | View |
| 2023-07-05 Purchase | 2023-07-06 07:45 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 1,176 | $15.52 | $18,252 | 2,529,201 (Direct) | View |
| 2023-06-26 Purchase | 2023-06-27 08:45 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 16,760 | $16.46 | $275,870 | 2,528,025 (Direct) | View |
| 2023-06-26 Purchase | 2023-06-27 08:45 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 750 | $16.5 | $12,375 | 3,230,779 (Direct) | View |
| 2023-06-23 Purchase | 2023-06-26 08:45 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 73,175 | $17.43 | $1,275,440 | 2,511,265 (Direct) | View |
| 2023-06-21 Purchase | 2023-06-23 08:59 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 13,090 | $17.72 | $231,964 | 2,438,090 (Direct) | View |
| 2023-06-21 Purchase | 2023-06-22 08:42 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 500 | $17.88 | $8,940 | 3,230,029 (Direct) | View |
| 2023-06-16 Purchase | 2023-06-20 08:25 am | Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner | 12,700 | $17.75 | $225,425 | 2,425,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-13 Option Award | 2024-06-13 4:22 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director | 30,000 | $0 | 83,760 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-13 4:22 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Hoberman Kenneth Director | 30,000 | $0 | 103,140 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-13 4:21 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Oliviero James F III Director | 30,000 | $0 | 57,828 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 4:31 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off | 130,000 | $0 | 1,503,819 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-05 4:30 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 130,000 | $0 | 1,491,955 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 08:16 am | N/A N/A | Nuvectis Pharma Inc. | NVCT | Oliviero James F III Director | 18,000 | $0 | 27,828 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 08:16 am | N/A N/A | Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director | 18,000 | $0 | 53,760 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 08:15 am | N/A N/A | Nuvectis Pharma Inc. | NVCT | Hoberman Kenneth Director | 18,000 | $0 | 73,140 (Direct) | View |